HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma.

AuthorsEmmanuelle Boulanger, Véronique Meignin, Eric Oksenhendler
JournalBritish journal of haematology (Br J Haematol) Vol. 141 Issue 4 Pg. 559-61 (May 2008) ISSN: 1365-2141 [Electronic] England
PMID18341641 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib
Topics
  • Adult
  • Antineoplastic Agents (therapeutic use)
  • Boronic Acids (therapeutic use)
  • Bortezomib
  • Female
  • Herpesviridae Infections (complications)
  • Herpesvirus 8, Human
  • Humans
  • Lymphoma, AIDS-Related (drug therapy)
  • Lymphoma, Primary Effusion (drug therapy)
  • Male
  • Middle Aged
  • Pyrazines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: